Nicole R. Braley’s Post

Looking forward to the surely interesting discussion on dealmaking in the Pharma industry. This ecosystem has brought incredible change to healthcare in the last decades and looking forward to tackle the unmet needs that still exists. Thanks to #reedsmith and #juliaboyd and #milantakker for getting this set up.

News and trends in Health Care and Life Sciences Dealmaking. Join our webinar on 26 October. Moderated by my partners Milan Thakker and Julia Boyd panels with industry experts will have a deep dive. Reed Smith Global Corporate Group Reed Smith Life Sciences Health Industry Group

On 25 January 2024, the Federal Trade Commission (FTC) sued to block Novant Health’s proposed US$320m acquisition of two North Carolina hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, from Community Health Systems. This article summarizes the first hospital merger challenge brought by the FTC under the new Merger Guidelines. #MergersAndAcquisitions #MergerControl #Competition #Antitrust #Healthcare #Hospitals

🩺 ICG to invest in Cura Day Hospitals Group alongside a consortium of healthcare professionals including Peter Freeleagus, Doctor Shareholders, and Cura Management 🩹 The strategic partnership will support Cura’s continued growth plan, founded on clinical and operational excellence 🔗 Read in full: https://lnkd.in/ew2jtWPs 💬👇🏽 James Giannas, Managing Director leading the Australia / New Zealand team for ICG #PrivateMarkets #PrivateCapital #Alternatives #Healthcare Capital at risk. Past performance is not a reliable indicator of future results.

Chris Yates, CEO and co-founder of Abingdon Health plc (AIM:ABDX), presented at the Proactive One2One Investor Conference, detailing the company's impressive growth and future plans. Founded in 2008 and headquartered in York, #AbingdonHealth specialises as a #LateralFlow CRO (Contract Research Organisation) and CDMO (Contract Development and Manufacturing Organisation). The company, with 83 employees primarily in #York and a secondary site in #Doncaster, primarily generates revenue through its contract service business, accounting for 95% of its income. Additionally, Abingdon Health has diversified into self-test products. Under Yates' leadership, the company has seen substantial revenue growth, reporting just under £5.5 million in the last 12 months and a cash position of nearly £2 million at 2023's end. The firm's expertise in #LateralFlowTest technology, significantly recognised during the #COVID19 pandemic, positions it well in a market expected to expand considerably over the next decade. Abingdon Health's services encompass the full spectrum of product development, from initial ideas to commercial success, including regulatory and analytical laboratory support. A key element of Abingdon Health's strategy is its focus on CRO and CDMO services, offering a broad portfolio of customers and a significant pipeline of opportunities. The company's business model, which enables long-term revenue through manufacturing customers, is set to drive future growth. Furthermore, the firm has launched self-test products under the "Abingdon Simply Test" brand and provides end-to-end support for retailers creating their own branded products. Watch at #Proactive #ProactiveInvestors #AIM #ABDX https://ow.ly/2M4s50QrCXl

At Pfizer, we believe ensuring diversity in clinical trials is a matter of equity, a value core to our culture. But achieving greater diversity in clinical research won’t happen overnight, and it won’t happen without commitment, coordination, and investment from many stakeholders across the healthcare ecosystem. That’s why we’re so proud to join a new collaboration, led by the SGM Alliance, to standardize best practices, champion change, and enhance accurate representation of LGBTQIA+ participants in clinical trials.   Learn more about this cross-industry initiative:  https://sgmalliance.org/

Tech-savvy, health-focused, and results-driven. Sound like a clinical trial organization you want to partner with? At Hawthorne Effect, we promise to change the way you view clinical trials, bringing you better, faster, and more effective results. All you have to do is say yes. #ClinicalTrials #HealthcareSolutions #HealthcareInnovation #PatientEnrollment

At Pfizer, we believe ensuring diversity in clinical trials is a matter of equity, a value core to our culture. But achieving greater diversity in clinical research won’t happen overnight, and it won’t happen without commitment, coordination, and investment from many stakeholders across the healthcare ecosystem. That’s why we’re so proud to join a new collaboration, led by the SGM Alliance, to standardize best practices, champion change, and enhance accurate representation of LGBTQIA+ participants in clinical trials. Learn more about this cross-industry initiative: https://sgmalliance.org/

Since 2016, West Virginia University Health System has folded 14 hospitals into its network — including three hospitals last year alone — creating an emerging 25-hospital Goliath that reaches into Pennsylvania, Ohio and Maryland. And in January, the health system, which is branded WVU Medicine, is expected to add the 218-bed Weirton Medical Center in the northern panhandle of West Virginia to the system portfolio, pending regulatory approval, as revenue from overall core operations increased 48.3% to $5.9 billion in 2023 from $3.8 billion in 2021, according to a new report from S&P Global Ratings. The New York City-based agency assigned WVU Medicine’s long-term debt an A rating with a stable outlook. #wvumedicine #healthcare #WVU #hospitals

On 25 January 2024, the Federal Trade Commission (FTC) sued to block Novant Health’s proposed US$320m acquisition of two North Carolina hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, from Community Health Systems. This article summarizes the first hospital merger challenge brought by the FTC under the new Merger Guidelines. #MergersAndAcquisitions #MergerControl #Competition #Antitrust #Healthcare #Hospitals